Crinetics Pharmaceuticals, Inc. (CRNX)

SEC filing

Crinetics Pharmaceuticals, Inc.

CRNX · CIK 1658247

4 · Nov 5, 2025 · Pizzuti Dana sold 5,000 shares at $42.66/share ($213.3K); exercised options for 5,000 shares

Pizzuti Dana sold 5,000 shares at $42.66/share ($213.3K); exercised options for 5,000 shares

FORM 4

xslF345X05/wk-form4_1762380006.xmlSEC.gov

Graphics and non-inline formats (not embedded below).